Skip to main content
Top
Published in: Diabetologia 4/2008

01-04-2008 | Article

Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80

Authors: S. Kadowaki, T. Okamura, A. Hozawa, T. Kadowaki, A. Kadota, Y. Murakami, K. Nakamura, S. Saitoh, Y. Nakamura, T. Hayakawa, Y. Kita, A. Okayama, H. Ueshima, for the NIPPON DATA Research Group

Published in: Diabetologia | Issue 4/2008

Login to get access

Abstract

Aims/hypothesis

High fasting blood glucose is one of the well-known risk factors for CHD. However, in certain settings, patients cannot always be expected to fast. For example, community screenings for cardiovascular disease (CVD) risk factors in Japan are performed under non-fasting conditions to achieve high participation rates. Thus, we examined a representative cohort of the Japanese population (n = 9,444, follow-up period 17.3 years) to clarify whether high casual blood glucose (CBG) can predict CVD mortality.

Methods

We defined CBG groups as follows: high CBG ≥ 11.1 mmol/l or participants with a history of diabetes mellitus; borderline high, 7.77 ≤ CBG < 11.1 mmol/l; higher normal, 5.22 ≤ CBG < 7.77 mmol/l); and lower normal, CBG < 5.22 mmol/l. The multivariate-adjusted hazard ratios (HRs) for CHD, CVD and all-cause mortality were calculated.

Results

The crude CHD mortality rate was 0.84 per 1,000 person-years. Age- and sex-adjusted HRs for CHD mortality were high among participants with CBG levels  ≥ 7.77 mmol/l, regardless of time since last meal. Multivariate-adjusted HRs (95% CI) of CHD mortality in high and borderline high CBG groups were 2.62 (1.46–4.67) and 2.43 (1.29–4.58), respectively. Similar results were observed for both CVD and all-cause mortality. Even within the normal blood glucose range, each 1 mmol/l increase in CBG was associated with a statistically significant increase in the HR for CVD mortality (1.12, 95% CI 1.02–1.22). Population-attributable fractions of the combined groups of high and borderline high CBG for CHD, CVD and all-cause mortality were 12.0, 4.9 and 3.5%, respectively.

Conclusions/interpretation

Increases in CBG, even within the normal range, predict CVD mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 287:867–870PubMedCrossRef Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 287:867–870PubMedCrossRef
2.
go back to reference Kannel WB, Mcgee DL (1979) Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035–2038PubMedCrossRef Kannel WB, Mcgee DL (1979) Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035–2038PubMedCrossRef
3.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444PubMedCrossRef Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444PubMedCrossRef
4.
go back to reference Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef
5.
go back to reference Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20
6.
go back to reference Irie F, Sairenchi T, Iso H, Shimamoto T (2001) Prediction of mortality from findings of annual health checkups utility for health care programs. Nippon Koshu Eisei Zasshi 48:95–108 (article in Japanese)PubMed Irie F, Sairenchi T, Iso H, Shimamoto T (2001) Prediction of mortality from findings of annual health checkups utility for health care programs. Nippon Koshu Eisei Zasshi 48:95–108 (article in Japanese)PubMed
7.
go back to reference Fujishima M, Kiyohara Y, Kato I et al (1996) Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45(Suppl 3):S14–S16PubMed Fujishima M, Kiyohara Y, Kato I et al (1996) Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45(Suppl 3):S14–S16PubMed
8.
go back to reference Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW (2002) Framingham offspring study: fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring study. Diabetes Care 25:1845–1850PubMedCrossRef Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW (2002) Framingham offspring study: fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring study. Diabetes Care 25:1845–1850PubMedCrossRef
9.
go back to reference Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG (2006) Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 29:26–31PubMedCrossRef Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG (2006) Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 29:26–31PubMedCrossRef
10.
go back to reference NIPPON DATA80 Research Group (2006) Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 70:1249–1255CrossRef NIPPON DATA80 Research Group (2006) Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 70:1249–1255CrossRef
11.
go back to reference Okamura T, Tanaka H, Miyamatsu N, for NIPPON DATA80 Research Group (2007) The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 190:216–223PubMedCrossRef Okamura T, Tanaka H, Miyamatsu N, for NIPPON DATA80 Research Group (2007) The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 190:216–223PubMedCrossRef
12.
go back to reference Ueshima H, Choudhury SR, Okayama A et al (2004) Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 35:1836–1841PubMedCrossRef Ueshima H, Choudhury SR, Okayama A et al (2004) Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 35:1836–1841PubMedCrossRef
13.
go back to reference Okamura T, Hayakawa T, Kadowaki T, et al., for NIPPON DATA80 research group (2004) A combination of serum low albumin and above-average cholesterol level was associated with excess mortality. J Clin Epidemiol 57:1188–1195PubMedCrossRef Okamura T, Hayakawa T, Kadowaki T, et al., for NIPPON DATA80 research group (2004) A combination of serum low albumin and above-average cholesterol level was associated with excess mortality. J Clin Epidemiol 57:1188–1195PubMedCrossRef
14.
go back to reference Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H, for Nippon Data80 Research Group (2003) What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 253:169–180PubMedCrossRef Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H, for Nippon Data80 Research Group (2003) What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 253:169–180PubMedCrossRef
15.
go back to reference Nakamura M, Sato S, Shimamoto T (2003) Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 10:145–153PubMed Nakamura M, Sato S, Shimamoto T (2003) Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 10:145–153PubMed
16.
go back to reference Bittner D, McCleary M (1963) The cupric-phenanthroline chelate in the determination of monosaccharides in whole blood. Am J Clin Pathol 40:423–424 Bittner D, McCleary M (1963) The cupric-phenanthroline chelate in the determination of monosaccharides in whole blood. Am J Clin Pathol 40:423–424
17.
go back to reference Iso H, Imano H, Kitamura A et al (2004) Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 47:2137–2144PubMedCrossRef Iso H, Imano H, Kitamura A et al (2004) Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 47:2137–2144PubMedCrossRef
18.
go back to reference Shirai K (2001) Evaluation of obesity and diagnostic criteria of obesity as a disease for Japanese (in Japanese). Nippon Rinsho 59:578–585PubMed Shirai K (2001) Evaluation of obesity and diagnostic criteria of obesity as a disease for Japanese (in Japanese). Nippon Rinsho 59:578–585PubMed
19.
go back to reference Nishi N, Sugiyama H, Kasagi F et al (2007) Urban-rural difference in stroke mortality from a 19-year cohort study of the Japanese general population: NIPPON DATA80. Soc Sci Med 65:822–832PubMedCrossRef Nishi N, Sugiyama H, Kasagi F et al (2007) Urban-rural difference in stroke mortality from a 19-year cohort study of the Japanese general population: NIPPON DATA80. Soc Sci Med 65:822–832PubMedCrossRef
20.
go back to reference Okamura T, Hayakawa T, Kadowaki T, for NIPPON DATA80 Research Group (2004) Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 147:1024–1032PubMedCrossRef Okamura T, Hayakawa T, Kadowaki T, for NIPPON DATA80 Research Group (2004) Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 147:1024–1032PubMedCrossRef
21.
go back to reference American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28(Suppl 1):S37–S42CrossRef American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28(Suppl 1):S37–S42CrossRef
22.
go back to reference Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 88:15–19PubMed Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 88:15–19PubMed
23.
go back to reference Sairenchi T, Iso H, Irie F et al (2005) Age-specific relationship between blood pressure and the risk of total and cardiovascular mortality in Japanese men and women. Hypertens Res 28:901–909PubMedCrossRef Sairenchi T, Iso H, Irie F et al (2005) Age-specific relationship between blood pressure and the risk of total and cardiovascular mortality in Japanese men and women. Hypertens Res 28:901–909PubMedCrossRef
24.
go back to reference Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Kuller LH (2001) Coronary heart disease mortality among men aged 35–44 years by prefecture in Japan in 1995–1999 compared with that among white men aged 35–44 by state in the United States in 1995–1998: vital statistics data in recent birth cohort. Jpn Circ J 65:887–892PubMedCrossRef Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Kuller LH (2001) Coronary heart disease mortality among men aged 35–44 years by prefecture in Japan in 1995–1999 compared with that among white men aged 35–44 by state in the United States in 1995–1998: vital statistics data in recent birth cohort. Jpn Circ J 65:887–892PubMedCrossRef
25.
go back to reference Sekikawa A, Horiuchi BY, Edmundowicz D et al (2003) A “natural experiment” in cardiovascular epidemiology in the early 21st century. Heart 89:255–257PubMedCrossRef Sekikawa A, Horiuchi BY, Edmundowicz D et al (2003) A “natural experiment” in cardiovascular epidemiology in the early 21st century. Heart 89:255–257PubMedCrossRef
26.
go back to reference Sekikawa A, Ueshima H, Zaky WR et al (2005) Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40–49 in Japan than in the US, despite a less favorable profile of major risk factors. Int J Epidemiol 34:173–179PubMedCrossRef Sekikawa A, Ueshima H, Zaky WR et al (2005) Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40–49 in Japan than in the US, despite a less favorable profile of major risk factors. Int J Epidemiol 34:173–179PubMedCrossRef
27.
go back to reference Kuriyama S, Shimazu T, Ohmori K et al (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki Study. JAMA 296:1255–1265PubMedCrossRef Kuriyama S, Shimazu T, Ohmori K et al (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki Study. JAMA 296:1255–1265PubMedCrossRef
28.
go back to reference Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef
29.
go back to reference Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731PubMedCrossRef Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731PubMedCrossRef
30.
go back to reference Franciosi M, De Berardis G, Rossi MC et al (2005) Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) Study. Diabetes Care 28:1187–1194PubMedCrossRef Franciosi M, De Berardis G, Rossi MC et al (2005) Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) Study. Diabetes Care 28:1187–1194PubMedCrossRef
31.
go back to reference Lawes CM, Bennett DA, Feigin VL, Rodgers A (2004) Blood pressure and stroke: an overview of published reviews. Stroke 35:776–785PubMedCrossRef Lawes CM, Bennett DA, Feigin VL, Rodgers A (2004) Blood pressure and stroke: an overview of published reviews. Stroke 35:776–785PubMedCrossRef
32.
go back to reference Asia Pacific Cohort Studies Collaboration (2003) Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 21:707–716CrossRef Asia Pacific Cohort Studies Collaboration (2003) Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 21:707–716CrossRef
33.
go back to reference Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913CrossRef Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913CrossRef
34.
go back to reference Lawes CM, Parag V, Bennett DA, for Asia Pacific Cohort Studies Collaboration (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836–2842PubMedCrossRef Lawes CM, Parag V, Bennett DA, for Asia Pacific Cohort Studies Collaboration (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836–2842PubMedCrossRef
35.
go back to reference Rodriguez BL, Lau N, Burchfiel CM et al (1999) Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 22:1262–1265PubMedCrossRef Rodriguez BL, Lau N, Burchfiel CM et al (1999) Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 22:1262–1265PubMedCrossRef
36.
go back to reference Rose G (1992) The strategy of preventive medicine. Oxford University Press, Oxford Rose G (1992) The strategy of preventive medicine. Oxford University Press, Oxford
37.
go back to reference MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774PubMedCrossRef MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774PubMedCrossRef
Metadata
Title
Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80
Authors
S. Kadowaki
T. Okamura
A. Hozawa
T. Kadowaki
A. Kadota
Y. Murakami
K. Nakamura
S. Saitoh
Y. Nakamura
T. Hayakawa
Y. Kita
A. Okayama
H. Ueshima
for the NIPPON DATA Research Group
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0915-6

Other articles of this Issue 4/2008

Diabetologia 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.